Acceleron Pharma
XLRN
#1812
Rank
S$14.16 B
Marketcap
S$231.64
Share price
0.00%
Change (1 day)
14,565.64%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: S$14.16 Billion

As of December 2025 Acceleron Pharma has a market cap of S$14.16 Billion. This makes Acceleron Pharma the world's 1812th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022S$14.65 B-0.84%
2021S$14.77 B44.92%
2020S$10.19 B168.56%
2019S$3.79 B37.97%
2018S$2.75 B7.19%
2017S$2.56 B84.17%
2016S$1.39 B-39.32%
2015S$2.29 B37.62%
2014S$1.66 B17.38%
2013S$1.42 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
S$230.20 B 1,525.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$98.66 B 596.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$630.46 B 4,350.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S$27.09 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.21 B-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
S$63.06 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$191.79 B 1,253.86%๐Ÿ‡บ๐Ÿ‡ธ USA